These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3937256

  • 21. [Calcitonin and parathyroid hormone secretion and calcium metabolism in patients with diffuse toxic goiter during treatment with lithium carbonate].
    Petrov NM.
    Probl Endokrinol (Mosk); 1984; 30(1):22-6. PubMed ID: 6424108
    [Abstract] [Full Text] [Related]

  • 22. [Use of combined complexes and lithium carbonate in the preoperative care of patients with toxic goiter].
    Slobozhanin MI, Chudnova VS, Kuznetsov IS.
    Klin Khir (1962); 1989; (12):32-3. PubMed ID: 2517312
    [Abstract] [Full Text] [Related]

  • 23. [Results of lithium treatment in severe hyperthyroidism].
    Wünsch C, Heberling HJ.
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(1):26-31. PubMed ID: 6423365
    [Abstract] [Full Text] [Related]

  • 24. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC, Pei D, Wang TF, Wu DA, Li JC, Wei CL, Lee CH, Chen SP, Kuo SW.
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [Abstract] [Full Text] [Related]

  • 25. [First experiences with short-term lithium therapy in severe thyrotoxicosis].
    Heberling HJ, Heilman W, Heintze M, Gauer J, Lohmann D.
    Z Gesamte Inn Med; 1981 Oct 01; 36(19):704-7. PubMed ID: 7303774
    [Abstract] [Full Text] [Related]

  • 26. [Radioisotope methods of control of the effectiveness of treatment of diffuse toxic goiter with mercazolyl].
    Egorenkov AN.
    Med Radiol (Mosk); 1976 Oct 01; 21(9):47-53. PubMed ID: 1036752
    [No Abstract] [Full Text] [Related]

  • 27. [Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture].
    Henzen C, Buess M, Brander L.
    Schweiz Med Wochenschr; 1999 May 01; 129(17):658-64. PubMed ID: 10407936
    [Abstract] [Full Text] [Related]

  • 28. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U, Gerber H, Peter HJ.
    Schweiz Med Wochenschr; 1995 Aug 08; 125(31-32):1489-94. PubMed ID: 7545825
    [Abstract] [Full Text] [Related]

  • 29. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE, Michanek AM, Holmberg EC, Fink M.
    J Nucl Med; 1996 Feb 08; 37(2):228-32. PubMed ID: 8667049
    [Abstract] [Full Text] [Related]

  • 30. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F, González-Ortiz M, Durón H, Sánchez C.
    Rev Invest Clin; 2002 Feb 08; 54(4):307-10. PubMed ID: 12415954
    [Abstract] [Full Text] [Related]

  • 31. [The effect of mercasolyl on immunologic indicators in patients with diffuse toxic goiter].
    Epishin AV, Solomko LD, Epishina NA, Kuz'mich IuP.
    Vrach Delo; 1989 Feb 08; (2):11-4. PubMed ID: 2711649
    [Abstract] [Full Text] [Related]

  • 32. [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
    Iangolenko VV.
    Ter Arkh; 1991 Feb 08; 63(10):60-3. PubMed ID: 1725225
    [Abstract] [Full Text] [Related]

  • 33. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH, Richards AR, Addison GM, Owen GM.
    Lancet; 1974 Nov 16; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of patients with toxic diffuse goiter].
    Spesivtseva VG.
    Klin Med (Mosk); 1983 Oct 16; 61(10):118-23. PubMed ID: 6417398
    [No Abstract] [Full Text] [Related]

  • 35. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J.
    Horm Res; 2008 Oct 16; 70(3):155-64. PubMed ID: 18663316
    [Abstract] [Full Text] [Related]

  • 36. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
    Bojarska-Szmygin A, Ciechanek R.
    Wiad Lek; 2003 Oct 16; 56(7-8):303-7. PubMed ID: 14969154
    [Abstract] [Full Text] [Related]

  • 37. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.
    Clin Invest Med; 1999 Aug 16; 22(4):132-9. PubMed ID: 10497711
    [Abstract] [Full Text] [Related]

  • 38. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M.
    Clin Endocrinol (Oxf); 2006 Feb 16; 64(2):189-95. PubMed ID: 16430719
    [Abstract] [Full Text] [Related]

  • 39. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
    Sewerynek J, Wiktorska J, Nowak D, Lewinski A.
    Endocr Regul; 2000 Jun 16; 34(2):83-9. PubMed ID: 10911409
    [Abstract] [Full Text] [Related]

  • 40. Graves' disease with severe iodine allergy: successful surgery after lithium carbonate treatment. Case report.
    Takami H, Shikata J.
    Eur J Surg; 1991 Aug 16; 157(8):489-90. PubMed ID: 1681939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.